Puneet Souda
Stock Analyst at Leerink Partners
(2.03)
# 2,821
Out of 4,786 analysts
211
Total ratings
47.98%
Success rate
-1.24%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $61.77 | +21.42% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $8.87 | +136.75% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $4.48 | -10.71% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $29.65 | +34.91% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $141.41 | +6.07% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $368.57 | +1.74% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $6.08 | +64.47% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $497.60 | +26.61% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $20.02 | +74.83% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $116.98 | +23.95% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $205.00 | +46.34% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $79.34 | +215.10% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $58.63 | +87.62% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $43.29 | +73.25% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $127.24 | +57.18% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.23 | +707.17% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $2.40 | +150.00% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $39.26 | -23.59% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $6.51 | +130.41% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $9.49 | +58.06% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $41.74 | +108.43% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $42.60 | +228.64% | 5 | Feb 24, 2022 |
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $61.77
Upside: +21.42%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $8.87
Upside: +136.75%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $4.48
Upside: -10.71%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $29.65
Upside: +34.91%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $141.41
Upside: +6.07%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $368.57
Upside: +1.74%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $6.08
Upside: +64.47%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $497.60
Upside: +26.61%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $20.02
Upside: +74.83%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $116.98
Upside: +23.95%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $205.00
Upside: +46.34%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $79.34
Upside: +215.10%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $58.63
Upside: +87.62%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $43.29
Upside: +73.25%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $127.24
Upside: +57.18%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.23
Upside: +707.17%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $2.40
Upside: +150.00%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $39.26
Upside: -23.59%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $6.51
Upside: +130.41%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $9.49
Upside: +58.06%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $41.74
Upside: +108.43%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $42.60
Upside: +228.64%